Congrats to the intrepid MIT-Harvard Biomechatronics lab.
Can agonist-antagonist myoneural interfaces be a promising adjunct to current reconstructive/ablative/osteointegrative surgery? Read on here.
On diabetic foot, wound healing, amputation prevention, and the merger of consumer tech with medical devices
Congrats to the intrepid MIT-Harvard Biomechatronics lab.
Can agonist-antagonist myoneural interfaces be a promising adjunct to current reconstructive/ablative/osteointegrative surgery? Read on here.
Leave a Reply